The Global 3D Bio Printing Market size is predicted to reach $5.2 billion by 2032, growing at a CAGR of 18% during the forecast period 2023-2032 according to the latest market research report published by IndustryARC. The rising focus on regenerative medicine as a potential solution for addressing various healthcare challenges has spurred the demand for 3D bioprinting technology. The high prevalence of chronic conditions are fueling the growth of the 3D Bio Printing Market during the forecast period, finds IndustryARC in its recent report, titled “3D Bio Printing Market Size, Share & Trends Analysis Report By Component (3D Bio Printer and Bio Ink), By Biomaterial (Hydrogel, Live Cells, Extracellular Matrix, Others), By Technology (Magnetic Levitation Bioprinting, Inkjet-Based Bioprinting, Syringe/Extrusion-Based Bioprinting, laser Assisted Bioprinting and Others), By Application (Drug Testing and Development, Tissue Engineering and Regenerative Medicine, Food Inspection, Research and Others), By End User (Hospital, Biopharmaceutical Company, Research Institutes and Academic Institutions and Others), By Geography – Global Opportunity Analysis & Industry Forecast, 2023-2032.”

Request Sample Research Report:

North America Holds the Highest Market Share:

North America region held a major market share of 40% in 2022. North America has been at the forefront of technological advancements in 3D bioprinting. The region is the place for many leading research institutions, universities, and companies that have been driving innovation and pushing the boundaries of bioprinting technology. Chronic diseases in North America is a significant driver for the growth of the 3D bioprinting market. For Instance, According to American Cancer Society Inc, In 2021. In the United States, there will be 609,360 cancer deaths and an estimated 1.9 million new cancer cases reported. Chronic diseases can result in organ failure, necessitating organ transplantation as a treatment option. However, the demand for organ transplants far exceeds the supply of available organs from traditional donation sources. 3D bioprinting offers a potential solution by providing the capability to create functional organs and tissues in the lab, personalized to the patient’s specific needs, reducing the dependency on scarce donor organs.

3D Bio Printing Market 2023-2032: Scope of the Report

Report Metric


Base Year Considered


Forecast Period




Market Size in 2032

$5.2 billion

Segments Covered

Component, Biomaterial, Technology, Application, End User and Region

Geographies Covered

North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Netherlands, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Taiwan, Malaysia and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa).

Key Market Players

1.      GE Healthcare Life Sciences

2.      Desktop Metal, Inc.

3.      Bico Group AB

4.      Cellink Global

5.      Revotek Co., Ltd.

6.      Advanced Solutions Life Sciences, LLC.

7.      Inventia Life Science Pty Ltd

8.      Aspect Biosystems Ltd

9.      ROKIT Healthcare, Inc.

10.  Regenovo

Get Access to Full Research Report:

3D Bio Printing Market Report – Key Takeaways:

  • Bio Ink Segment is Leading the Market.

In the 3D Bio Printing Market analysis, Bio Ink held a major market share of 61% in 2022. The 3D bio-ink market is driven by the increasing demand for 3D printing in the medical and healthcare sector and the rising demand for 3D printed organs and tissues. The increasing demand for 3D-printed medical implants and prosthetics is also projected to drive the growth of the 3D bio-ink market. For instance, in 2022, the Sustainable Smart Factory Competition is a program run by the UK government’s Research and Innovation Agency (UKRI), which announced an investment of £14M ($14.74M) towards innovative solutions. Companies that pledge to use technology to drive energy efficiency, productivity, and growth across key manufacturing industries have received funding. Technological advancements and government schemes are contributing to market growth. increases the efficiency of snipping thereby rising demand for 3D Bio Printing.

  • Research Institutes and Academic Institutions Segment to Register Highest Growth.

According to the 3D Bio Printing Market forecast, the Research Institutes and Academic Institutions segment is analyzed to grow with the highest CAGR of 19% during the forecast period. Research institutes and academic institutions are also leveraging 3d bioprinting technology to facilitate experiments, prototypes, and medical instruments, driving the growth of the market in research institutes and academic institutions. For instance, in 2022, Cellink and Lonza announced their collaboration. Lonza contributes its wide range of culture-growth media and primary cells obtained from humans. The Cellink product range is significantly increased when Lonza’s components are added to meet a variety of research demands. The rise in collaborations and partnerships is also anticipated to drive market growth.

  • Technological Advancements and R&D Investments is a Key Driver Enhancing the Growth of the Market.

Technological advancements in miniaturization have led to the development of organ-on-a-chip devices, which replicate the structure and function of human organs on a small scale. These devices have potential applications in drug testing, toxicity screening, and personalized medicine. On 31st March 2023, A $480,000 grant has been awarded to a University of Montana research center to help with the procurement of a three-dimensional bioprinter, which would enable the nanofabrication of microscopic objects. The funds will be used to buy the Quantum X Bio System, a highly accurate bioprinter that can create small medication delivery systems, sensors, and tissue-like structures from biomaterials. R&D investments play a crucial role in driving the growth and advancement of the 3D bioprinting market. As a relatively new and rapidly evolving technology, continuous research and development efforts are necessary to improve the capabilities, scalability, and commercial viability of 3D bioprinting.

Purchase this Premium Report:

Key Opportunity Analysis:

Biomedical Research Advancements is Creating Growth Opportunities in the Market.

The rapid advancements in biomedical research present a substantial growth opportunity for the 3D bio printing market. As researchers gain deeper insights into tissue engineering and regenerative medicine, the demand for sophisticated 3D bio printing technologies escalates. The ability to precisely recreate complex biological structures enhances drug testing, disease modeling, and personalized medicine. The 3D bio printing market stands to benefit significantly from collaborations between biotechnology firms, research institutions, and healthcare providers, fostering innovation and expanding the application scope of 3D bio printing in the biomedical field. This growth factor is propelled by the continuous evolution of scientific knowledge and its translation into practical applications, positioning 3D bio printing as a pivotal player in cutting-edge biomedical research.

Rising Demand for Organ Transplants is Major Opportunity for Market Growth.

The escalating demand for organ transplants, coupled with a persistent shortage of donor organs, represents a significant growth avenue for the 3D bio printing market. The ability to engineer functional, transplantable organs using 3D bio printing technology addresses a critical gap in the healthcare landscape. As the prevalence of organ failure-related conditions rises globally, the demand for alternative solutions becomes imperative. 3D bio printing offers a promising avenue for creating patient-specific organs, reducing transplant rejection risks, and alleviating the burden on organ donation systems. Collaborations between research institutions, medical professionals, and biotechnology companies are pivotal in harnessing this opportunity, driving advancements in organ bioprinting and positioning the 3D bio printing market at the forefront of transformative healthcare solutions.

If you have any questions, please feel free to contact our experts at:

The Report also Covers the Following Areas:

  • 3D Bio Printing Market Size and Forecast
  • 3D Bio Printing Market Trends
  • 3D Bio Printing Market Analysis by Type

3D Bio Printing Market 2023-2032: Key Highlights

  • CAGR of the market during the forecast period 2023-2032
  • Value Chain analysis of key stake holders
  • Detailed analysis of market drivers and opportunities during the forecast period
  • 3D Bio Printing Market size estimation and forecast.
  • Analysis and predictions on end users’ behavior and upcoming trends
  • Competitive landscape and Vendor market analysis including offerings, developments, and financials.
  • Comprehensive analysis of challenges and constraints in the 3D Bio Printing Market.


Covid and Ukrainian Crisis Impact:

  • The 3D bioprinting market relies on a global supply chain for materials and components. During the pandemic, disruptions in transportation and manufacturing caused delays in the delivery of critical bioprinting materials and equipment. The pandemic highlighted the importance of medical research and advanced healthcare solutions. This emphasis could drive increased interest and funding in the 3D bioprinting market, particularly for applications in regenerative medicine and drug testing. For instance, On 30 November 2021, The University Health Network (UHN), a pioneer in the field of stem cell research and regenerative medicine, and Aspect Biosystems, a biotechnology firm developing bio printed cell treatments as medicines of the future, signed a research partnership.
  • The 3D Bio Printing Market in Russia and Ukraine has faced significant disruption due to the ongoing war. Heightened geopolitical tensions and economic uncertainties have impacted the supply chain, causing disruptions in the procurement of essential materials for 3D bio printing. Companies reliant on Ukrainian suppliers are experiencing challenges, potentially leading to delays in production and increased costs. The crisis underscores the vulnerability of interconnected markets, emphasizing the importance of diversification and risk mitigation strategies in the 3D bio printing industry. Stakeholders are closely monitoring developments, adapting strategies to navigate this complex geopolitical landscape.     

To Get a Customized Industry Analysis, Speak with our Research Analyst:

List of Key Market Players in 3D Bio Printing Market:

The key companies profiled in the 3D Bio Printing Market Report are listed below:

  • GE Healthcare Life Sciences
  • Desktop Metal, Inc.
  • Bico Group AB
  • Cellink Global
  • Revotek Co., Ltd.
  • Advanced Solutions Life Sciences, LLC.
  • Inventia Life Science Pty Ltd
  • Aspect Biosystems Ltd
  • ROKIT Healthcare, Inc.
  • Regenovo

Related Reports:

3D Printing Market – The 3D Printing Market size is projected to grow at a CAGR of 20% from 2024 to 2030. The market is majorly driven by important characteristics i.e. increasing number of government investments in 3D printing projects, ease in production, customizable products and reduction in manufacturing cost.

3D Printed Medical Devices Market – The 3D Printed Medical Devices Market size is projected to grow at a CAGR of 15% during the forecast period. The heightened application of 3D printing technology to offer the advantages of customized treatments at an economical price to the patients is set to propel the growth of the 3D Printed Medical Devices Market.

3D Printed Biosensors Market – The 3D Printed Biosensors Market size is growing at a CAGR of 9.8% during the forecast period. The growing government initiatives to promote the usage of 3D printers for Industrial applications will create usage of 3D printers in medical applications, thereby positively impacting the 3D Printed Biosensors industry outlook.  

About IndustryARC™:

IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets. 

IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format which assists an intelligent and informed decision-making process.


Contact Us:

Mr. Venkat Reddy


Email: [email protected]

USA: (+1) 518 282 4727


Follow us on: LinkedIn | Facebook | Twitter

Tags: , , , , , , , , ,

See Campaign:

Contact Information:

Mr. Venkat Reddy IndustryARC Email: [email protected] USA: (+1) 518 282 4727

BNN, Extended Distribution, iCN Internal Distribution, Wire, Research Newswire, English